MEET YOUR HOST,
JEANNIE MAI JENKINS
Pursue Your Passions
Television host and stylist Jeannie Mai Jenkins shares why she’s passionate about inspiring people with multiple sclerosis (MS) to express themselves.
Click here to sign up to receive exclusive Express4MS content from Jeannie Mai Jenkins.
Living with MS doesn’t have to stop you from expressing yourself. Jeannie interviews a diverse group of people about their experiences living with MS, the obstacles they’ve faced and how they have learned to express themselves with their loved ones, the MS community, their healthcare providers, and the WORLD! Scroll to hear their stories.
Learn about a professional basketball player’s MS diagnosis and treatment journey
Hear how Sagal’s family has been supportive in her MS journey
Find out more how an ER nurse has navigated life with MS
Explore how Chris expresses himself through his passion for reading and learning
Go on a culinary adventure with Sagal and Jeannie as they discuss the power of a good meal
Go on a journey with Eleisha as she expresses herself through exploring new and interesting places
Follow along as Sagal talks about life with MS as a college student
MEET SONJA:
Expressing Herself Through Art
Hello, my name is Sonja. I have relapsing-remitting multiple sclerosis, but that doesn’t stop me from expressing myself. I’m excited to share my story and experience with Express4MS …
MEET RON:
Expressing Himself With Strength
Hello, my name is Ron. I have relapsing-remitting multiple sclerosis, but that doesn’t stop me from expressing myself. I like to say that my life has been a 3-round fight …
GET EXCLUSIVE
EXPRESS4MS CONTENT
from Jeannie Mai Jenkins by filling out the form below
Your healthcare provider will continue to monitor your health during the 2 yearly treatment courses, and for at least another 2 years during which you do not need to take MAVENCLAD. It is not known if MAVENCLAD is safe and effective in people who restart MAVENCLAD treatment more than 2 years after completing 2 yearly treatment courses.
The most common side effects of MAVENCLAD include: upper respiratory infection, headache, and low white blood cell counts.
These are not all the possible side effects of MAVENCLAD. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see full Prescribing Information/Medication Guide, including serious side effects, for additional Important Safety Information.
©2022 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada. MAVENCLAD and MS LifeLines are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.
Your healthcare provider will continue to monitor your health during the 2 yearly treatment courses, and for at least another 2 years during which you do not need to take MAVENCLAD. It is not known if MAVENCLAD is safe and effective in people who restart MAVENCLAD treatment more than 2 years after completing 2 yearly treatment courses.
The most common side effects of MAVENCLAD include: upper respiratory infection, headache, and low white blood cell counts.
These are not all the possible side effects of MAVENCLAD. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Please see full Prescribing Information/Medication Guide, including serious side effects, for additional Important Safety Information.
©2022 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved. EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada. MAVENCLAD and MS LifeLines are registered trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.